Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
Pharmacists’ role in dementia care
Dementia Australia recently called for shared responsibility between healthcare professionals and aged care organisations in the care of people living with dementia. But where...
Prophylactic antibiotics for STIs
Chlamydia, gonorrhoea and syphilis are all sexually transmitted infections, predominately spread through sexual contact.
Variety (and better wages) are key for ECPs
Bridgette Mackley MPS is a community pharmacist in Coffs Harbour, NSW, and PSA’s NSW Intern of the Year.
Harm minimisation strategies for party season
As we head into festival season, revellers from most states and territories could be placed in a potentially deadly situation.
Improving gout management one step at a time
Gout is a chronic arthritis associated with significant pain, joint damage and reduced quality of life. However, it can be effectively treated and its complications prevented with adherence to lifelong ULT using a treat-to-target approach.
Your most pressing questions answered
This month Amanda Fairjones, Professional Support Advisor, and Peter Guthrey, Senior Pharmacist answer your questions about COVID-19 vaccine requirements and the new nicotine vaping guidelines.
